DHR vs V: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Visa Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Visa Inc. · Financial Services
$304.36
+37.7% upside to fair value
High Conviction
Grade A-
QuantHub Verdict
V has more upside to fair value
(+37.7%).
V trades at a lower forward P/E
(23.7x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
V |
| Current Price |
$174.04 |
$304.36 |
| Fair Value Estimate |
$197.01 |
$419.00 |
| Upside to Fair Value |
+13.2%
|
+37.7%
|
| Market Cap |
$123.2B |
$586.8B |
| Forward P/E |
33.4x
|
23.7x
|
| EV / EBITDA |
20.3x
|
22.3x
|
| Price / Sales |
5.0x
|
14.2x
|
| Price / FCF |
23.3x
|
25.6x
|
| Revenue Growth YoY |
+3.7%
|
+11.3%
|
| Gross Margin |
60.7%
|
81.08%
|
| Operating Margin |
21.0%
|
59.18%
|
| Return on Equity |
7.1%
|
54.22%
|
| Dividend Yield |
0% |
0.83% |
| FCF Yield |
4.3%
|
3.91%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Visa is the world's dominant payment network with $40B in net revenue (FY2025), 50%+ net margins, and a capital-light toll-booth model processing $14.2T in annual payment volume across 257.5B transactions. The business compounds at 10-12% revenue CAGR with operating leverage pushing EPS growth to 12-15% over a cycle, funded by $21.6B in annual free cash flow against only $1.5B in capex. At 28.0x …
Accumulation Zones
| Metric |
DHR |
V |
| Zone Low |
$147.76 |
$265.00 |
| Zone High |
$167.46 |
$300.00 |
| In Buy Zone? |
No
|
No
|